Hollyhigh International Capital

Hollyhigh Capital is a leading Chinese investment bank which focuses on enterprise M&A across the healthcare industry with the core businesses of M&A/sales/financing consultation, buyout funds, cross-border M&A, etc. It aims to develop into a leading international investment bank that provides full-service for comprehensive healthcare enterprises M&A and upgrades. www.hollyhigh.cn ,//, Most of Hollyhighs core team members graduated from top Chinese and International academies such as Tsinghua, Peking University School of Pharmaceutical Sciences (SPS) China Pharmaceutical University and Imperial College London. Mr. James Chen, the companys founder, graduated from Tsinghua University School of Economics and Management and was rated as...

医药企业并购/出售/融资顾问,医药企业并购基金,医药企业跨境并购,and fda iii期生物新药投资收购

Hollyhigh international capital operates in the Investment banking industry.

Hollyhigh international capital's revenue is 11m - 100m

Hollyhigh international capital has 11 - 50 employees.